2 Healthcare Stocks Receiving New Wall Street Analyst Coverage

Wall St. Watchdog reveals information about companies for which stock analysts initiated coverage in the Healthcare sector for the week ending November 11th, 2011.

  • Seattle Genetics (NASDAQ:SGEN): Needham initiated coverage of this company with a rating of Buy and a price target of $20 on Nov 11th. The shares recently traded at $16.20, down $0.32, or 1.94% since the analyst’s rating. About the company: Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company’s technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer. Get the most recent company news and stock data here >>
  • Micromet (NASDAQ:MITI): Needham initiated coverage of this company with a rating of Buy and a price target of $10 on Nov 11th. The shares recently traded at $6.01, down $0.19, or 3.06% since the analyst’s rating. About the company: Micromet, Inc. is a biotechnology company. The Company develops novel antibody-based drugs for the treatment of cancer, inflammation and autoimmune diseases. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Briefing.com via the Wall St. Journal. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

More from The Cheat Sheet